Genome Institute of Singapore


Standort der Organisation:
Singapore, Singapur

Publikationen in Kooperation mit FAU-Wissenschaftlerinnen und Wissenschaftlern

Go to first page Go to previous page 1 von 2 Go to next page Go to last page
Vachon, C.M., Scott, C.G., Tamimi, R.M., Thompson, D.J., Fasching, P., Stone, J.,... Garcia-Closas, M. (2019). Joint association of mammographic density adjusted for age and body mass index and polygenic risk score with breast cancer risk. Breast Cancer Research, 21.
Berner, D., Pasutto, F., Hoja, U., Zenkel, M., Ozaki, M., Williams, S.,... Schlötzer-Schrehardt, U. (2018). Pseudoexfoliation associated protective variant, rs7173049, reveals a novel regulatory region downstream of LOXL1.
Haycock, P.C., Burgess, S., Nounu, A., Zheng, J., Okoli, G.N., Bowden, J.,... Smith, G.D. (2017). Association Between Telomere Length and Risk of Cancer and Non-Neoplastic Diseases: A Mendelian Randomization Study. JAMA Oncology, 3(5), 636-651.
Kadalayil, L., Khan, S., Nevanlinna, H., Fasching, P., Couch, F.J., Hopper, J.L.,... Tapper, W. (2017). Germline variation in ADAMTSL1 is associated with prognosis following breast cancer treatment in young women. Nature Communications, 8(1).
Pasutto, F., Zenkel, M., Hoja, U., Berner, D., Uebe, S., Ferrazzi, F.,... Schlötzer-Schrehardt, U. (2017). Pseudoexfoliation syndrome-associated genetic variants affect transcription factor binding and alternative splicing of LOXL1. Nature Communications, 8, 15466.
Fagerholm, R., Khan, S., Schmidt, M.K., Garcia-Closas, M., Heikkila, P., Saarela, J.,... Nevanlinna, H. (2017). TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancer. Oncotarget, 8(11), 18381-18398.
Muranen, T.A., Blomqvist, C., Doerk, T., Jakubowska, A., Heikkila, P., Fagerholm, R.,... Nevanlinna, H. (2016). Patient survival and tumor characteristics associated with CHEK2:p.I157T - findings from the Breast Cancer Association Consortium. Breast Cancer Research, 18(1).
Aung, T., Ozaki, M., Mizoguchi, T., Allingham, R.R., Li, Z., Haripriya, A.,... Khor, C.-C. (2015). A common variant mapping to CACNA1A is associated with susceptibility to exfoliation syndrome. Nature Genetics, 47(4), 387-92.
Carvajal-Carmona, L.G., O'Mara, T.A., Painter, J.N., Lose, F.A., Dennis, J., Michailidou, K.,... Thompson, D.J. (2015). Candidate locus analysis of the TERT-CLPTM1L cancer risk region on chromosome 5p15 identifies multiple independent variants associated with endometrial cancer risk. Human genetics, 134(2), 231-45.
Painter, J.N., O'Mara, T.A., Batra, J., Cheng, T., Lose, F.A., Dennis, J.,... Spurdle, A.B. (2015). Fine-mapping of the HNF1B multicancer locus identifies candidate variants that mediate endometrial cancer risk. Human Molecular Genetics, 24(5), 1478-92.
Zhang, B., Shu, X.-O., Delahanty, R.J., Zeng, C., Michailidou, K., Bolla, M.K.,... Zheng, W. (2015). Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization. Journal of the National Cancer Institute, 107(11).
Kabisch, M., Bermejo, J.L., Duennebier, T., Ying, S., Michailidou, K., Bolla, M.K.,... Hamann, U. (2015). Inherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancer. Carcinogenesis, 36(2), 256-71.
Rudolph, A., Milne, R.L., Truong, T., Knight, J.A., Seibold, P., Flesch-Janys, D.,... Chang-Claude, J. (2015). Investigation of gene-environment interactions between 47 newly identified breast cancer susceptibility loci and environmental risk factors. International Journal of Cancer, 136(6), E685-96.
Darabi, H., Mccue, K., Beesley, J., Michailidou, K., Nord, S., Kar, S.,... Chenevix-Trench, G. (2015). Polymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 Expression. American Journal of Human Genetics, 97(1), 22-34.
Fagerholm, R., Schmidt, M.K., Khan, S., Rafiq, S., Tapper, W., Aittomaki, K.,... Nevanlinna, H. (2015). The SNP rs6500843 in 16p13.3 is associated with survival specifically among chemotherapy-treated breast cancer patients. Oncotarget, 6(10), 7390-407.
Li, J., Lindstroem, L.S., Foo, J.N., Rafiq, S., Schmidt, M.K., Pharoah, P.D.P.,... Czene, K. (2014). 2q36.3 is associated with prognosis for oestrogen receptor-negative breast cancer patients treated with chemotherapy. Nature Communications, 5, 4051.
Milne, R.L., Herranz, J., Michailidou, K., Dennis, J., Tyrer, J.P., Zamora, M.P.,... Easton, D.F. (2014). A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46 450 cases and 42 461 controls from the breast cancer association consortium. Human Molecular Genetics, 23(7), 1934-46.
Milne, R.L., Burwinkel, B., Michailidou, K., Arias-Perez, J.-I., Pilar Zamora, M., Menendez-Rodriguez, P.,... Easton, D.F. (2014). Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium. Human Molecular Genetics, 23(22), 6096-111.
Justenhoven, C., Pentimalli, D., Rabstein, S., Harth, V., Lotz, A., Pesch, B.,... Brauch, H. (2014). CYP2B6*6 is associated with increased breast cancer risk. International Journal of Cancer, 134(2), 426-30.
Agarwal, D., Pineda, S., Michailidou, K., Herranz, J., Pita, G., Moreno, L.T.,... Milne, R.L. (2014). FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium. British Journal of Cancer, 110(4), 1088-100.

Zuletzt aktualisiert 2016-15-08 um 13:49